Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005681 | spliceosomal complex | 3 | 11 |
GO:0005840 | ribosome | 5 | 11 |
GO:0032991 | protein-containing complex | 1 | 11 |
GO:0043226 | organelle | 2 | 11 |
GO:0043228 | non-membrane-bounded organelle | 3 | 11 |
GO:0043229 | intracellular organelle | 3 | 11 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 11 |
GO:0071013 | catalytic step 2 spliceosome | 3 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:0140513 | nuclear protein-containing complex | 2 | 11 |
GO:1902494 | catalytic complex | 2 | 11 |
GO:1990904 | ribonucleoprotein complex | 2 | 11 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: A0A3Q8IDI9
Term | Name | Level | Count |
---|---|---|---|
GO:0000375 | RNA splicing, via transesterification reactions | 8 | 11 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 9 | 11 |
GO:0000398 | mRNA splicing, via spliceosome | 8 | 11 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 11 |
GO:0006396 | RNA processing | 6 | 11 |
GO:0006397 | mRNA processing | 7 | 11 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0008380 | RNA splicing | 7 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0016070 | RNA metabolic process | 5 | 11 |
GO:0016071 | mRNA metabolic process | 6 | 11 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0046483 | heterocycle metabolic process | 3 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:0090304 | nucleic acid metabolic process | 4 | 11 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0003729 | mRNA binding | 5 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 308 | 312 | PF00656 | 0.489 |
CLV_NRD_NRD_1 | 108 | 110 | PF00675 | 0.646 |
CLV_NRD_NRD_1 | 220 | 222 | PF00675 | 0.783 |
CLV_NRD_NRD_1 | 41 | 43 | PF00675 | 0.701 |
CLV_NRD_NRD_1 | 59 | 61 | PF00675 | 0.413 |
CLV_PCSK_FUR_1 | 106 | 110 | PF00082 | 0.588 |
CLV_PCSK_KEX2_1 | 105 | 107 | PF00082 | 0.558 |
CLV_PCSK_KEX2_1 | 108 | 110 | PF00082 | 0.566 |
CLV_PCSK_KEX2_1 | 220 | 222 | PF00082 | 0.783 |
CLV_PCSK_KEX2_1 | 40 | 42 | PF00082 | 0.705 |
CLV_PCSK_PC1ET2_1 | 105 | 107 | PF00082 | 0.542 |
CLV_PCSK_PC1ET2_1 | 40 | 42 | PF00082 | 0.705 |
CLV_PCSK_SKI1_1 | 156 | 160 | PF00082 | 0.435 |
CLV_PCSK_SKI1_1 | 184 | 188 | PF00082 | 0.454 |
CLV_PCSK_SKI1_1 | 259 | 263 | PF00082 | 0.415 |
CLV_PCSK_SKI1_1 | 336 | 340 | PF00082 | 0.320 |
CLV_PCSK_SKI1_1 | 371 | 375 | PF00082 | 0.259 |
CLV_PCSK_SKI1_1 | 486 | 490 | PF00082 | 0.487 |
CLV_PCSK_SKI1_1 | 507 | 511 | PF00082 | 0.343 |
DEG_SPOP_SBC_1 | 203 | 207 | PF00917 | 0.745 |
DOC_CKS1_1 | 7 | 12 | PF01111 | 0.660 |
DOC_CYCLIN_yCln2_LP_2 | 499 | 505 | PF00134 | 0.478 |
DOC_MAPK_gen_1 | 486 | 496 | PF00069 | 0.483 |
DOC_PP1_RVXF_1 | 422 | 429 | PF00149 | 0.479 |
DOC_PP2B_LxvP_1 | 159 | 162 | PF13499 | 0.452 |
DOC_PP4_FxxP_1 | 158 | 161 | PF00568 | 0.435 |
DOC_PP4_FxxP_1 | 187 | 190 | PF00568 | 0.568 |
DOC_USP7_MATH_1 | 203 | 207 | PF00917 | 0.743 |
DOC_USP7_MATH_1 | 266 | 270 | PF00917 | 0.483 |
DOC_USP7_MATH_1 | 271 | 275 | PF00917 | 0.493 |
DOC_USP7_MATH_1 | 282 | 286 | PF00917 | 0.441 |
DOC_USP7_MATH_1 | 417 | 421 | PF00917 | 0.468 |
DOC_USP7_UBL2_3 | 482 | 486 | PF12436 | 0.502 |
DOC_WW_Pin1_4 | 385 | 390 | PF00397 | 0.513 |
DOC_WW_Pin1_4 | 52 | 57 | PF00397 | 0.545 |
DOC_WW_Pin1_4 | 6 | 11 | PF00397 | 0.674 |
DOC_WW_Pin1_4 | 91 | 96 | PF00397 | 0.755 |
LIG_14-3-3_CanoR_1 | 252 | 262 | PF00244 | 0.472 |
LIG_14-3-3_CanoR_1 | 379 | 385 | PF00244 | 0.560 |
LIG_14-3-3_CanoR_1 | 41 | 49 | PF00244 | 0.611 |
LIG_14-3-3_CanoR_1 | 453 | 459 | PF00244 | 0.490 |
LIG_14-3-3_CanoR_1 | 463 | 470 | PF00244 | 0.427 |
LIG_APCC_ABBA_1 | 425 | 430 | PF00400 | 0.500 |
LIG_APCC_ABBAyCdc20_2 | 424 | 430 | PF00400 | 0.504 |
LIG_BRCT_BRCA1_1 | 204 | 208 | PF00533 | 0.535 |
LIG_CSL_BTD_1 | 499 | 502 | PF09270 | 0.431 |
LIG_EVH1_1 | 63 | 67 | PF00568 | 0.627 |
LIG_FHA_1 | 256 | 262 | PF00498 | 0.472 |
LIG_FHA_1 | 284 | 290 | PF00498 | 0.459 |
LIG_FHA_1 | 302 | 308 | PF00498 | 0.354 |
LIG_FHA_1 | 402 | 408 | PF00498 | 0.413 |
LIG_FHA_1 | 504 | 510 | PF00498 | 0.461 |
LIG_FHA_2 | 306 | 312 | PF00498 | 0.410 |
LIG_FHA_2 | 372 | 378 | PF00498 | 0.457 |
LIG_FHA_2 | 409 | 415 | PF00498 | 0.521 |
LIG_FHA_2 | 52 | 58 | PF00498 | 0.547 |
LIG_FHA_2 | 7 | 13 | PF00498 | 0.659 |
LIG_LIR_Apic_2 | 157 | 161 | PF02991 | 0.431 |
LIG_LIR_Apic_2 | 383 | 389 | PF02991 | 0.515 |
LIG_LIR_Nem_3 | 497 | 503 | PF02991 | 0.398 |
LIG_PCNA_PIPBox_1 | 493 | 502 | PF02747 | 0.468 |
LIG_PCNA_yPIPBox_3 | 486 | 500 | PF02747 | 0.477 |
LIG_PDZ_Class_1 | 516 | 521 | PF00595 | 0.457 |
LIG_PDZ_Wminus1_1 | 519 | 521 | PF00595 | 0.395 |
LIG_SH2_CRK | 386 | 390 | PF00017 | 0.524 |
LIG_SH2_NCK_1 | 53 | 57 | PF00017 | 0.657 |
LIG_SH2_SRC | 34 | 37 | PF00017 | 0.703 |
LIG_SH2_STAP1 | 340 | 344 | PF00017 | 0.371 |
LIG_SH2_STAT5 | 153 | 156 | PF00017 | 0.491 |
LIG_SH2_STAT5 | 34 | 37 | PF00017 | 0.696 |
LIG_SH2_STAT5 | 353 | 356 | PF00017 | 0.452 |
LIG_SH2_STAT5 | 464 | 467 | PF00017 | 0.470 |
LIG_SH2_STAT5 | 475 | 478 | PF00017 | 0.470 |
LIG_SH2_STAT5 | 53 | 56 | PF00017 | 0.429 |
LIG_SH3_1 | 61 | 67 | PF00018 | 0.617 |
LIG_SH3_2 | 502 | 507 | PF14604 | 0.414 |
LIG_SH3_3 | 133 | 139 | PF00018 | 0.605 |
LIG_SH3_3 | 4 | 10 | PF00018 | 0.692 |
LIG_SH3_3 | 407 | 413 | PF00018 | 0.459 |
LIG_SH3_3 | 499 | 505 | PF00018 | 0.414 |
LIG_SH3_3 | 61 | 67 | PF00018 | 0.617 |
LIG_SUMO_SIM_par_1 | 48 | 55 | PF11976 | 0.662 |
LIG_WRC_WIRS_1 | 262 | 267 | PF05994 | 0.463 |
LIG_WW_1 | 235 | 238 | PF00397 | 0.530 |
LIG_WW_3 | 178 | 182 | PF00397 | 0.471 |
MOD_CK1_1 | 117 | 123 | PF00069 | 0.635 |
MOD_CK1_1 | 285 | 291 | PF00069 | 0.458 |
MOD_CK1_1 | 367 | 373 | PF00069 | 0.532 |
MOD_CK1_1 | 79 | 85 | PF00069 | 0.690 |
MOD_CK1_1 | 94 | 100 | PF00069 | 0.470 |
MOD_CK2_1 | 154 | 160 | PF00069 | 0.500 |
MOD_CK2_1 | 161 | 167 | PF00069 | 0.502 |
MOD_CK2_1 | 213 | 219 | PF00069 | 0.695 |
MOD_CK2_1 | 371 | 377 | PF00069 | 0.457 |
MOD_CK2_1 | 408 | 414 | PF00069 | 0.523 |
MOD_CK2_1 | 42 | 48 | PF00069 | 0.639 |
MOD_CK2_1 | 51 | 57 | PF00069 | 0.590 |
MOD_DYRK1A_RPxSP_1 | 6 | 10 | PF00069 | 0.599 |
MOD_GlcNHglycan | 116 | 119 | PF01048 | 0.661 |
MOD_GlcNHglycan | 200 | 203 | PF01048 | 0.720 |
MOD_GlcNHglycan | 215 | 218 | PF01048 | 0.748 |
MOD_GlcNHglycan | 221 | 224 | PF01048 | 0.681 |
MOD_GlcNHglycan | 225 | 228 | PF01048 | 0.599 |
MOD_GlcNHglycan | 243 | 246 | PF01048 | 0.343 |
MOD_GlcNHglycan | 449 | 452 | PF01048 | 0.311 |
MOD_GlcNHglycan | 466 | 469 | PF01048 | 0.257 |
MOD_GlcNHglycan | 78 | 81 | PF01048 | 0.648 |
MOD_GSK3_1 | 198 | 205 | PF00069 | 0.698 |
MOD_GSK3_1 | 219 | 226 | PF00069 | 0.628 |
MOD_GSK3_1 | 271 | 278 | PF00069 | 0.457 |
MOD_GSK3_1 | 285 | 292 | PF00069 | 0.457 |
MOD_GSK3_1 | 301 | 308 | PF00069 | 0.328 |
MOD_GSK3_1 | 367 | 374 | PF00069 | 0.524 |
MOD_GSK3_1 | 445 | 452 | PF00069 | 0.457 |
MOD_GSK3_1 | 503 | 510 | PF00069 | 0.359 |
MOD_GSK3_1 | 71 | 78 | PF00069 | 0.681 |
MOD_GSK3_1 | 79 | 86 | PF00069 | 0.714 |
MOD_GSK3_1 | 87 | 94 | PF00069 | 0.755 |
MOD_N-GLC_1 | 254 | 259 | PF02516 | 0.503 |
MOD_N-GLC_1 | 361 | 366 | PF02516 | 0.257 |
MOD_N-GLC_1 | 367 | 372 | PF02516 | 0.257 |
MOD_NEK2_1 | 116 | 121 | PF00069 | 0.679 |
MOD_NEK2_1 | 154 | 159 | PF00069 | 0.474 |
MOD_NEK2_1 | 253 | 258 | PF00069 | 0.440 |
MOD_NEK2_1 | 261 | 266 | PF00069 | 0.474 |
MOD_NEK2_1 | 275 | 280 | PF00069 | 0.509 |
MOD_NEK2_1 | 361 | 366 | PF00069 | 0.457 |
MOD_NEK2_1 | 484 | 489 | PF00069 | 0.422 |
MOD_NEK2_1 | 494 | 499 | PF00069 | 0.443 |
MOD_PIKK_1 | 266 | 272 | PF00454 | 0.454 |
MOD_PIKK_1 | 408 | 414 | PF00454 | 0.523 |
MOD_PK_1 | 42 | 48 | PF00069 | 0.683 |
MOD_PKA_1 | 40 | 46 | PF00069 | 0.610 |
MOD_PKA_2 | 219 | 225 | PF00069 | 0.653 |
MOD_PKA_2 | 40 | 46 | PF00069 | 0.610 |
MOD_Plk_1 | 361 | 367 | PF00069 | 0.457 |
MOD_Plk_1 | 377 | 383 | PF00069 | 0.457 |
MOD_Plk_1 | 484 | 490 | PF00069 | 0.485 |
MOD_Plk_4 | 154 | 160 | PF00069 | 0.525 |
MOD_Plk_4 | 161 | 167 | PF00069 | 0.583 |
MOD_Plk_4 | 204 | 210 | PF00069 | 0.669 |
MOD_Plk_4 | 34 | 40 | PF00069 | 0.700 |
MOD_Plk_4 | 356 | 362 | PF00069 | 0.457 |
MOD_Plk_4 | 66 | 72 | PF00069 | 0.773 |
MOD_ProDKin_1 | 385 | 391 | PF00069 | 0.510 |
MOD_ProDKin_1 | 52 | 58 | PF00069 | 0.543 |
MOD_ProDKin_1 | 6 | 12 | PF00069 | 0.665 |
MOD_ProDKin_1 | 91 | 97 | PF00069 | 0.749 |
TRG_DiLeu_BaEn_1 | 325 | 330 | PF01217 | 0.486 |
TRG_DiLeu_BaLyEn_6 | 434 | 439 | PF01217 | 0.456 |
TRG_ENDOCYTIC_2 | 238 | 241 | PF00928 | 0.462 |
TRG_ER_diArg_1 | 106 | 109 | PF00400 | 0.608 |
TRG_ER_diArg_1 | 435 | 438 | PF00400 | 0.406 |
TRG_NLS_MonoExtC_3 | 104 | 109 | PF00514 | 0.638 |
TRG_Pf-PMV_PEXEL_1 | 437 | 441 | PF00026 | 0.523 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PDB3 | Leptomonas seymouri | 70% | 98% |
A0A1X0NZP7 | Trypanosomatidae | 51% | 100% |
A0A3R7NW31 | Trypanosoma rangeli | 51% | 100% |
A0A3S7WR72 | Leishmania donovani | 23% | 100% |
A4HE87 | Leishmania braziliensis | 86% | 100% |
A4HUJ0 | Leishmania infantum | 23% | 100% |
A4I1N3 | Leishmania infantum | 100% | 100% |
C9ZK82 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 50% | 100% |
E9AN88 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 22% | 100% |
E9AXR7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
O74855 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 26% | 100% |
Q4Q9Q4 | Leishmania major | 95% | 100% |
V5BRZ9 | Trypanosoma cruzi | 51% | 98% |